PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35391601-0	2022	Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence.	nitazoxanide	78-90	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	25-30	
35391601-4	2022	Here, we demonstrate that nitazoxanide, an antiprotozoal agent with recognized broad-spectrum antiviral activity, interferes with SARS-CoV-2 spike maturation, hampering its terminal glycosylation at an endoglycosidase H-sensitive stage.	nitazoxanide	26-38	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	141-146	
35391601-6	2022	Nitazoxanide, being equally effective against the ancestral SARS-CoV-2 Wuhan-spike and different emerging variants, including the Delta variant of concern, may represent a useful tool in the fight against COVID-19 infections.	nitazoxanide	0-12	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	77-82